Ovid Therapeutics (FRA:1OT) Accounts Payable & Accrued Expense : €7.02 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Ovid Therapeutics Accounts Payable & Accrued Expense?

Ovid Therapeutics's quarterly accounts payable & accrued expense increased from Sep. 2023 (€6.97 Mil) to Dec. 2023 (€9.38 Mil) but then declined from Dec. 2023 (€9.38 Mil) to Mar. 2024 (€7.02 Mil).

Ovid Therapeutics's annual accounts payable & accrued expense declined from Dec. 2021 (€13.10 Mil) to Dec. 2022 (€6.10 Mil) but then increased from Dec. 2022 (€6.10 Mil) to Dec. 2023 (€9.38 Mil).

Ovid Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Ovid Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovid Therapeutics Accounts Payable & Accrued Expense Chart

Ovid Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

9.48

16.32

13.10

6.10

9.38

Ovid Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															5.53	8.49	6.97	9.38	7.02

Ovid Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Ovid Therapeutics (FRA:1OT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovid Therapeutics Inc (FRA:1OT) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

OVID:USA

Address

441 Ninth Avenue, 14th Floor, New York, NY, USA, 10001

Website

https://www.ovidrx.com

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class or best-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Ovid Therapeutics (FRA:1OT) Headlines

No Headlines